The discovery of non-enzymatic functions of BTK began with seminal studies aimed at elucidating the molecular mechanisms underlying X-linked agammaglobulinemia (XLA), a primary immunodeficiency disorder resulting from mutations in the BTK gene. The gene discussed is BTK; the disease is Bruton-type agammaglobulinemia.